C
Cryptobiotix provides preclinical research services focused on deciphering gut interactions using its proprietary _ex vivo_ SIFR® technology pipeline. This platform simulates digestion, the gut microbiome, and host responses to deliver mechanistic insights into product efficacy. The resulting validated data supports clients in securing intellectual property, preparing regulatory dossiers, and de-risking clinical trials.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Cryptobiotix develops preclinical research services focused on understanding the impact of ingested actives on digestion and the gut microbiome. The company utilizes its proprietary _ex vivo_ SIFR® technology pipeline to simulate the human GI tract and colonic fermentation under physiological conditions. This provides validated, predictive mechanistic insights to support IP development, regulatory submissions, and clinical trial de-risking.